How is AI transforming drug discovery and accelerating scientific breakthroughs in personalized medicine? SilicoGene explored this question last week at World Summit AI 2024 and the answer is clear: their innovation could reshape the future of healthcare! SilicoGene’s mission is to simplify drug discovery with its no-code platform for pharmaceutical and healthcare companies. Responsible AI accelerates the road to personalized medicine where drugs are tailored to someone’s genetic profile.
Nobel Prize in Chemistry
‘During the AI event in Amsterdam we were able to display our work to a lot of people and made many valuable connections,’ CEO Hossein Kamkar says. In the same week as the summit, the Nobel Prize committee announced that the Nobel Prize in Chemistry was awarded to the developers of AlphaFold, an AI system that predicts protein structures. Kamkar: ‘Everyone at the event was asking us: will you be running for this Nobel Prize next?’ Who knows! Participation in the Next Valley program and the support of Back Albert Groenewoud will certainly help SilcoGene follow the right path.
Published – 15/10/24